达拉非尼是ATP竞争型的 Raf 抑制剂,抑制 C-Raf 和 B-RafV600E 的 IC50 分别为 5 nM 和 0.6 nM,是一种用于治疗与突变基因BRAF相关的癌症的药物,作为相关酶B-RAF的抑制剂,在细胞生长的调节中起着一定的作用。

清空选项
1195768-19-4 Methyl 3-(2,6-difluorophenylsulfonamido)-2-fluorobenzoate
BD2895331195768-19-497%
¥151.00250mg常备现货
13036-57-2 2-Chloro-4-methylpyrimidine
BD1797713036-57-298%
¥530.00100g常备现货
1195768-23-0 N-(3-(2-(tert-Butyl)-5-(2-chloropyrimidin-4-yl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide
BD4500521195768-23-097%
¥999.00250mg常备现货
630-22-8 2,2-Dimethylpropanethioamide
BD165536630-22-895%
¥2223.00100g常备现货
1195768-18-3 Methyl 3-amino-2-fluorobenzoate
BD2379131195768-18-398%
¥89.001g常备现货
60230-36-6 2,6-Difluorobenzene-1-sulfonyl chloride
BD976360230-36-698%
¥56.0010g常备现货
1195768-06-9 N-(3-(5-(2-Aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide methanesulfonate
BD007505711195768-06-999%
¥253.00100mg常备现货
1195768-20-7 N-(3-(2-(2-Chloropyrimidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide
BD4500561195768-20-797%
¥97.00100mg
1